Stay updated on Avelumab and Palbociclib in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab and Palbociclib in Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Two new quick links, 'Check who can join' and 'Find Contact Information', were added to the history page to aid navigation and access. The page now shows the site release as Revision: v3.6.0, replacing the previous Revision: v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-14T06:26:47.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the study record history, replacing the previous v3.5.4 entry.
    Difference
    0.1%
    Check dated 2026-06-07T02:33:06.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 has been added to the Record History, updating the version list; the previous revision v3.5.3 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-05-16T09:07:05.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s footer application/version indicator updates from revision v3.5.2 to v3.5.3, indicating a platform release rather than changes to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-25T05:21:53.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The record history now includes revision v3.5.2 and removes revision v3.5.0. This is a metadata update to the history log rather than substantive study information.
    Difference
    0.1%
    Check dated 2026-04-18T00:21:09.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The PALAVY study record title was updated to 'Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)'. The update also adds IPDSharing, Study Status, and Study Identification fields, replacing the prior title variant.
    Difference
    0.7%
    Check dated 2026-04-10T18:57:51.000Z thumbnail image

Stay in the know with updates to Avelumab and Palbociclib in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.